Select Medical (NYSE:SEM – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.55 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
Select Medical (NYSE:SEM – Get Free Report) last posted its quarterly earnings results on Friday, February 23rd. The health services provider reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Select Medical had a net margin of 3.65% and a return on equity of 16.93%. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the company posted $0.22 EPS. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, analysts expect Select Medical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Select Medical Stock Performance
NYSE:SEM opened at $28.36 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.32. Select Medical has a fifty-two week low of $21.28 and a fifty-two week high of $33.51. The stock has a market cap of $3.64 billion, a PE ratio of 14.85, a price-to-earnings-growth ratio of 1.08 and a beta of 1.37. The firm’s fifty day simple moving average is $28.28 and its 200-day simple moving average is $25.83.
Select Medical Announces Dividend
Insider Buying and Selling
In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the sale, the chairman now owns 6,689,668 shares of the company’s stock, valued at approximately $200,021,073.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 17.50% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on SEM. Benchmark restated a “buy” rating and issued a $39.00 target price on shares of Select Medical in a report on Friday, April 12th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, March 22nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $34.40.
Read Our Latest Report on Select Medical
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Read More
- Five stocks we like better than Select Medical
- EV Stocks and How to Profit from Them
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Hilton Demonstrates Asset Light is Right for Investors
- 5 Top Rated Dividend Stocks to Consider
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.